Blockage of the RAS with ACE inhibitors or ARBs has become one of the most successful therapeutic strategies in many cardiovascular diseases, including arterial hypertension, left ventricular systolic dysfunction, chronic heart failure, myocardial infarction, and diabetic and nondiabetic chronic kidney disease [36]. This evidence concerns the gene ACE and chronic kidney disease.